PET Imaging in the Evaluation of Cancer Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".
Deadline for manuscript submissions: closed (25 March 2024) | Viewed by 1578
Special Issue Editors
Interests: molecular imaging; PET; breast cancer; prostate cancer; neuroendocrine tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit your manuscript to this Special Issue entitled “PET imaging in the Evaluation of Cancer Treatment”. PET/CT and/or PET/MRI provide a hybrid functional and morphological imaging, which is particularly useful to guide clinicians for treatment selection, to evaluate the response to oncological treatments, and to assess recurrence and clinical outcomes. Despite several response criteria having been proposed (i.e., EORTC and PERCIST criteria), they are not always used in clinical practice and are unable to correctly assess the response to treatment in 100% of cases. Other parameters, such as volumetric ones, are often published in research papers but are not currently included in any response criteria.
This call is open to all papers investigating PET imaging in cancer treatment assessment. We will evaluate papers discussing the role of PET imaging in the selection and eligibility of patients for a determined cancer treatment. Moreover, papers discussing the therapy response based on PET/CT findings, whether with the use of recognised response criteria, visual assessment, semiquantitative parameters, or radiomics and artificial intelligence, will be considered. Finally, we will also consider papers discussing the role of PET imaging in follow-up, both for recurrence assessment and for the evaluation of patients’ outcomes.
We aim at publishing high-quality original articles, reviews, and metanalysis able to have a significant impact on clinical practice.
Dr. Luca Urso
Dr. Angelo Castello
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET/CT or PET/MRI
- treatment selection
- therapy response assessment
- response criteria
- semi-quantitative parameters
- radiomics features
- artificial intelligence
- targeted therapy
- recurrence
- survival
